A Study of the Safety and Effectiveness of Blenderized Tube Feedings in Adult Patients on Home Enteral Nutrition
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 13-008822
Sponsor Protocol Number: 13-008822
About this study
The purpose of this study is to find the effectiveness of blenderized tube feedings in adult people started on the Home Enteral Nutrition Program.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- Patients returning to Mayo Clinic, Rochester in 6-12 weeks following the initiation of HEN for their primary medical condition
- Willingness to undergo nutrition evaluation during that visit
- Willingness to either complete online weekly nutrition surveys or mail in weekly pre-stamped paper nutrition surveys for 6 weeks
- Patients who have PEG tube for enteral feeding
Exclusion Criteria
- A diagnosis of Glycogen storage disease or Lysosomal storage disorder
- Subjects who are unable/ unwilling to prepare BTF safely (as determined by the HEN team)
- Pregnant patients
- Patients who do not have either a follow–up visit scheduled or not interested in a follow-up after 12 weeks
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Manpreet Mundi, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available